首页> 美国卫生研究院文献>other >STRUCTURAL AND FUNCTIONAL INTERACTION OF FATTY ACIDS WITH HUMAN LIVER FATTY ACID BINDING PROTEIN (L-FABP) T94A VARIANT
【2h】

STRUCTURAL AND FUNCTIONAL INTERACTION OF FATTY ACIDS WITH HUMAN LIVER FATTY ACID BINDING PROTEIN (L-FABP) T94A VARIANT

机译:脂肪酸与人肝脂肪酸结合蛋白(L-FABP)T94A的结构和功能相互作用

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The human liver fatty acid binding protein (L-FABP) T94A variant, the most common in the FABP family, has been associated with elevated liver triglyceride (TG) levels. How this amino acid substitution elicits these effects is not known. This issue was addressed with human recombinant wild-type (WT, T94T) and T94A variant L-FABP proteins as well as cultured primary human hepatocytes expressing the respective proteins (genotyped as TT, TC, and CC). T94A substitution did not or only slightly alter L-FABP binding affinities for saturated, monounsaturated, or polyunsaturated long chain fatty acids (LCFA), nor did it change the affinity for intermediates in TG synthesis. Nevertheless, T94A substitution markedly altered the secondary structural response of L-FABP induced by binding LCFA or intermediates of TG synthesis. Finally, T94A substitution markedly diminished polyunsaturated fatty acid, eicosapentaenoic acid (EPA) or docosahexaenoic acid (DHA), induction of peroxisome proliferator-activated receptor alpha (PPARα) - regulated proteins such as L-FABP, fatty acid transport protein 5 (FATP5), and PPARα itself in cultured primary human hepatocytes. Thus, while T94A substitution did not alter the affinity of human L-FABP for LCFAs, it significantly altered human L-FABP structure and stability as well as conformational and functional response to these ligands.
机译:在FABP家族中最常见的人类肝脏脂肪酸结合蛋白(L-FABP)T94A变体与肝脏甘油三酸酯(TG)水平升高有关。这种氨基酸取代如何引起这些作用尚不清楚。人重组野生型(WT,T94T)和T94A变异L-FABP蛋白以及表达相应蛋白(基因型为TT,TC和CC)的培养的原代人肝细胞已解决了该问题。对于饱和,单不饱和或多不饱和长链脂肪酸(LCFA),T94A取代不会或仅轻微改变L-FABP结合亲和力,也不会改变对TG合成中间体的亲和力。然而,T94A取代显着改变了由结合LCFA或TG合成中间体诱导的L-FABP的二级结构响应。最后,T94A取代显着减少了多不饱和脂肪酸,二十碳五烯酸(EPA)或二十二碳六烯酸(DHA),诱导了过氧化物酶体增殖物激活受体α(PPARα)-调节的蛋白质,例如L-FABP,脂肪酸转运蛋白5(FATP5)和原代人肝细胞中的PPARα本身。因此,尽管T94A取代并没有改变人L-FABP对LCFA的亲和力,但它显着改变了人L-FABP的结构和稳定性以及对这些配体的构象和功能响应。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号